Psilocybin Microdosing: Trends, Research, and Legal Landscape in the USA

The growing interest in US psilocybin microdose capsules reflects a transformation in treatment paradigms.

What is considered a dose of psilocybin?

A common microdose ranges between 0.1 mg to 0.3 mg of pure psilocybin, far below the copyright threshold used in clinical trials.

Therapeutic use of psilocybin

Latest research suggest the potential of psilocybin microdoses in treating depression, is psilocybin a scheduled drug with thousands treated with psilocybin reporting reduced anxiety.

Legality

Is psilocybin legal in the US? Legal status is state‑dependent, such as Maryland and certain US jurisdictions moving toward medical legalization.

• Potential side effects are usually minimal, such as headache.
• Academic papers highlight variations in potency.
• Psilocybin clinical trials Canada contribute additional insight on clinical benefits.

News psilocybin this week reinforce that controlled dosing is becoming mainstream across the US.